Drug Profile
Research programme: antibody therapeutics - ID Pharma
Latest Information Update: 28 Jan 2018
Price :
$50
*
At a glance
- Originator ID Pharma
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Jan 2018 No recent reports of development identified for research development in Undefined in Japan (Parenteral)